PROGRAM
Day 1
| [Cross-specialty] Tricuspid Regurgitation: Precision in Complexity – Right Valve, Right Therapy, Right Time Chairperson: Duk-Hyun Kang (Ulsan Univ. / Korea), Kyung-Hwan Kim (Seoul National Univ. / Korea) |
English Session | |
|---|---|---|
| 09:00-09:15 | Managing Tricuspid Regurgitation: Where Are We and Where Are We Going? (Overview) | 70 |
| 09:15-09:30 | Restoring Rhythm, Relieving Regurgitation: The Impact of Rhythm Control in TR | 193 |
| 09:30-09:45 | Surgical Interventions in TR: Timing It Right, Doing It Right | 206 |
| 09:45-10:00 | Transcatheter Therapies on the Rise: T-TEER and the Future of TR Intervention | 216 |
| 10:00-10:20 | Discussion | |
| Coffee Break | ||
|---|---|---|
| [Cross-specialty] Imaging the Failing Heart: Echo Across the Spectrum of Heart Failure Chairperson: Seok Min Kang (Yonsei Univ.), Ji Yong Choi (Daegu Catholic Univ.) |
||
|---|---|---|
| 10:50-11:05 | Echocardiography in Shock: Diagnosing the Mechanism and Guiding Therapy | 31 |
| 11:05-11:20 | Assessing Volume and Congestion in Heart Failure: What Echo Can (and Can’t) Tell Us | 149 |
| 11:20-11:35 | Imaging for LVAD Patients: Preoperative Assessment, Post-Implant Monitoring, and Troubleshooting | 24 |
| 11:35-11:50 | Imaging in Heart Transplant Recipients: Surveillance, Rejection, and Graft Function | 43 |
| 11:50-12:10 | Discussion | |
| Lunch & Scientific Session (3)_Johnson & Johnson Chairperson: Hyuck-Jae Chang (Yonsei Univ.) |
||
|---|---|---|
| 12:20-12:50 | Uptravi in PAH: Advanced Initiation Strategies for Long-Term Outcomes | 7 |
| 12:50-13:20 | PAH Optimal Treatment with Opsynvi – One Formulation , Dual Impact | 133 |
| Debate [Pericardial Effusion] Pericardial Effusion, PCC or Not ? Chairperson: Tae-Ho Park (Donga Univ.), Seongwoo Han (Hallym Univ.) |
||
|---|---|---|
| 13:20-13:35 | Voting & Overview | 160 |
| 13:35-13:50 | Pericardiocentesis Need to Be Considered If Possible for the Diagnosis of Pericardial Effusion, Regardless of Hemodynamic Status | 103 |
| 13:50-14:05 | Pericardiocentesis Should Be Considered Only in Cases of Hemodynamic Compromise | 83 |
| 14:05-14:20 | Crossfire & Expert Panel Discussion | |
| 14:20-14:40 | Voting & Wrap Up | |
| Coffee Break | ||
|---|---|---|
| [Cross-specialty] Severe Bicuspid Aortic Valve Stenosis in Non-High Risk Surgical Patients Chairperson: Shin-Jae Kim (Ulsan Univ.), Kiyuk Chang (Catholic Univ.) |
||
|---|---|---|
| 15:10-15:25 | Bicuspid Aortic Valve: What It Is, Why It Matters, and What We Need to Know | 90 |
| 15:25-15:40 | Intervention-Focused CT Imaging in Bicuspid Aortic Valve: What We Must Consider | 15 |
| 15:40-15:55 | TAVI in Bicuspid Aortic Valve Stenosis: Techniques, Evidence, and Unmet Needs | 96 |
| 15:55-16:10 | When Surgery Is Still the Right Answer for High-Risk Bicuspid Aortic Valve Patients | 195 |
| 16:10-16:30 | Panel Discussion | |
